| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 1387.9 | 1173.1 | 919.0 |
| Other income | 33.6 | 11.0 | 25.4 |
| Total income | 1421.5 | 1184.1 | 944.4 |
| Profit before exceptional items & tax | 98.2 | 70.7 | 57.3 |
| Profit before tax | 98.2 | 70.7 | 57.3 |
| Net profit | 98.6 | 53.8 | 46.7 |
| Operating margin | 6.9% | 6.0% | 6.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +111.10% |
|---|---|
| Net profit, quarter on quarter | +83.30% |
| Revenue, year on year | +51.00% |
| Operating profit, year on year | +102.50% |
| Operating profit, quarter on quarter | +8.20% |
BSE results filing, NSE: COSMOFIRST. Figures extracted from the filing.
Cosmo First Ltd: key numbers
- Share price
- ₹766.70
- Market cap
- ₹2,013 Cr
- Revenue (annual)
- ₹3,639 Cr
- Net profit (annual)
- ₹156.0 Cr
- P/E (TTM)
- 12.1×Sector 45.1×
- Promoter holding
- 40.78%+0.00% QoQ
- FII holding
- 3.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cosmo First Ltd
All →Cosmo First Results Update
Cosmo First released Q2 FY27 consolidated results via press release, showing EBITDA and PAT growth. Net debt was reduced while B2B and consumer businesses scaled up.
Cosmo First Board Meeting Date
COSMO FIRST Limited will hold a board meeting on 03-Nov-2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. Trading window closes from 01-Oct-2026 until 48 hours after results are published.
Cosmo First Acquisition Worth ₹6.1 Cr
Cosmo First Limited is acquiring Prolife Speciality Vet Clinic LLP for a cash consideration of ₹6.10 Crore to expand its Petcare division, Zigly.
- Value
- ₹6.10 Cr
Cosmo First Acquisition
Cosmo First Ltd will acquire Prolife Speciality Vet Clinic LLP in Mumbai via a slump sale to expand its petcare division. Consideration terms were not disclosed.
Cosmo First Earnings Call Transcript: Key Takeaways
Cosmo First reported strong Q1FY26 consolidated performance with 16% revenue growth and 38% EBITDA growth YoY, driven by higher volumes and cost rationalization.
- Call
- Guides 20% growth
Cosmo First Investor Presentation: Key Takeaways
Cosmo First delivered strong Q1 FY27 revenue growth of 46% YoY to ₹1,166 Cr, driven by specialty films, chemical growth, and consumer business scaling.